Transaction in Own Shares

Summary by AI BETAClose X

Achilles Investment Company Limited has purchased 20,000 of its ordinary shares on the London Stock Exchange for £20,700, with these shares to be held in treasury. Following this transaction, the company now holds 20,000 shares in treasury, resulting in a total of 53,980,000 ordinary shares with voting rights. The company is entering a close period and has instructed its broker to conduct further market purchases of its shares during this time, acting under an authority granted by shareholders to acquire up to 14.99% of its issued shares.

Disclaimer*

Achilles Investment Company Limited
09 September 2026
 

9 September 2026

Achilles Investment Company Limited

Transaction in Own Shares

Achilles Investment Company Limited (the "Company") announces that on 9 September 2026 it purchased 20,000 of its ordinary shares (the "Shares") at a price of 103.5p on the London Stock Exchange for a total consideration (excluding expenses) of £20,700. The Shares will be held in treasury.

Following this purchase, and on the basis of the Company's issued share capital of 54,000,000 ordinary shares, the Company now holds 20,000 ordinary shares in treasury, which do not carry voting rights. The total number of ordinary shares in issue with voting rights following this purchase, for use by shareholders as the denominator for calculations under the FCA's Disclosure Guidance and Transparency Rules, is therefore 53,980,000 ("Total Voting Rights").

The Company is about to enter a close period ahead of the publication of its audited results for the period ended 30 June 2026. Accordingly, the Board has given Singer Capital Markets Securities Limited ("Singers"), the Company's broker, an irrevocable and non-discretionary instruction to undertake market purchases of the Company's ordinary shares on the Company's behalf during this close period.

This purchase was made pursuant to the authority granted to the Board by Shareholders at the Company's annual general meeting held on 28 October 2025, under which the Company was authorised, in accordance with section 315 of The Companies (Guernsey) Law, 2008 (as amended), to make market acquisitions of up to 14.99 per cent. of its ordinary shares in issue as at the date of that meeting, either for cancellation or to be held as treasury shares, at a price of not less than £0.01 per Share and not more than the maximum price permitted under the terms of that authority.

Enquiries:

Achilles Investment Company Limited

Charlotte Denton, Chair 

 

Tel: +44 (0) 1481 743030

 

 

Harwood Capital Management (Gibraltar) Limited (Investment Manager)

Robert Naylor 

 

Tel: +44 (0) 20 7640 3200

 

Singer Capital Markets (Financial Adviser)

James Moat / James Fischer - Corporate Finance

Alan Geeves / Sam Greatrex - Sales

 

Tel: +44 (0) 20 7496 3000

NSM Funds Limited (Secretary)

 

Tel: +44 (0) 1481 743 030

achilles@nsm.group

 

 

ISIN: GG00BT3GKD08

TIDM: AIC

LEI: 213800IVO9DDEIJD7724

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings